International Alliance for Personalised Medicine (IPM Alliance) shared on LinkedIn:
“The Politics of Making Innovation Work.
The 2026 China-Italy Anti-Cancer Summit brought together leaders from both countries to examine holistic cancer management, national cancer networks, virtual communities, psycho-oncology and the relationship between mind, body and environment. At its centre is one policy question: can healthcare systems absorb innovation as quickly as science now produces it?
The gap is increasingly not discovery, but delivery. New diagnostics, medicines and digital tools still depend on trained professionals, effective clinical pathways, interoperable data, sustainable financing and political leadership.
Professor Daiming Fan’s principle of ‘harmony in diversity’ offers a useful direction: harmonisation without homogenisation. China and Italy do not need identical cancer systems, but they do need compatible approaches to evidence, quality, data, workforce readiness and patient-centred implementation.
Cooperation should therefore focus on the machinery that moves innovation into routine care: readiness assessments, integrated patient pathways, multidisciplinary training, comparable outcome measures, data infrastructure and stronger links between specialist centres and underserved regions. Psycho-oncology and virtual communities belong within this agenda, supported by clear accountability, privacy protections and sustainable financing.
The summit’s practical test is simple: does cooperation reduce the distance between scientific progress and the patient?”
Other articles about IPM Alliance on OncoDaily.